Conference item
Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 229.5KB, Terms of use)
-
- Publisher copy:
- 10.1002/pds.4629
Authors
- Publisher:
- Wiley
- Host title:
- Pharmacoepidemiology and Drug Safety
- Journal:
- Pharmacoepidemiology and Drug Safety More from this journal
- Volume:
- 27
- Pages:
- 185-186
- Publication date:
- 2018-08-17
- DOI:
- EISSN:
-
1099-1557
- ISSN:
-
1053-8569
- Keywords:
- Pubs id:
-
pubs:920190
- UUID:
-
uuid:b0f81716-5bd0-4490-a6c2-eec79f1a0291
- Local pid:
-
pubs:920190
- Source identifiers:
-
920190
- Deposit date:
-
2019-03-27
- ARK identifier:
Terms of use
- Copyright holder:
- Alarkawi et al
- Copyright date:
- 2018
- Notes:
- © 2018 The Authors. This paper was presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic, August 22–26, 2018. This is the Accepted Manuscript version of the article. The final version is available online from Wiley at: https://doi.org/10.1002/pds.4629
If you are the owner of this record, you can report an update to it here: Report update to this record